glp 1 oral for weight loss GLP-1 Orforglipron Is Approved Obesity Ro Launches Wegovy® Pill Through
Description
By 2024, Ozempic had surpassed Trulicity, also approved for type 2 diabetes (not obesity) to make up the largest share of GLP-1 prescriptions and spending (39% in 2024)
Its prevalence is estimated to increase to 1.02 billion by 2030 [1]
By combining the convenience of virtual care with the tax advantages of FSAs and HSAs, FSA Store and HSA Store make it easier than ever to invest in long-term health and wellness
Your prescriber will discuss anything specific to your medical history
